A 784168 - CAS 824982-41-4
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C19H15F6N3O3S
Molecular Weight:
479.4
COA:
Inquire
Targets:
TRP Channel
Description:
A 784168 is a potent and selective TRPV1 antagonist (IC50 = 25 nM for inhibition of TRPV1 activation by 50 nM capsaicin) exhibiting no activity against a range of receptors such as TRPA1, GABA, opioid, and purinergic receptors.
Brife Description:
TRPV1 antagonist
Purity:
≥99% by HPLC
Synonyms:
3,6-Dihydro-3'-(trifluoromethyl)-N-[4-[(trifluoromethyl)sulfonyl]phenyl]-[1(2H),2'-bipyridine]-4-carboxamide; 1-[3-(trifluoromethyl)pyridin-2-yl]-N-[4-(trifluoromethylsulfonyl)phenyl]-3,6-dihydro-2H-pyridine-4-carboxamide
MSDS:
Inquire
InChIKey:
SDUAWRFBHRAFBM-UHFFFAOYSA-N
InChI:
InChI=1S/C19H15F6N3O3S/c20-18(21,22)15-2-1-9-26-16(15)28-10-7-12(8-11-28)17(29)27-13-3-5-14(6-4-13)32(30,31)19(23,24)25/h1-7,9H,8,10-11H2,(H,27,29)
Canonical SMILES:
C1CN(CC=C1C(=O)NC2=CC=C(C=C2)S(=O)(=O)C(F)(F)F)C3=C(C=CC=N3)C(F)(F)F
1.TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
Cui M;Honore P;Zhong C;Gauvin D;Mikusa J;Hernandez G;Chandran P;Gomtsyan A;Brown B;Bayburt EK;Marsh K;Bianchi B;McDonald H;Niforatos W;Neelands TR;Moreland RB;Decker MW;Lee CH;Sullivan JP;Faltynek CR J Neurosci. 2006 Sep 13;26(37):9385-93.
Vanilloid receptor type 1 (TRPV1) is a ligand-gated nonselective cation channel that is considered to be an important integrator of various pain stimuli such as endogenous lipids, capsaicin, heat, and low pH. In addition to expression in primary afferents, TRPV1 is also expressed in the CNS. To test the hypothesis that the CNS plays a differential role in the effect of TRPV1 antagonists in various types of pain, the analgesic effects of two TRPV1 antagonists with similar in vitro potency but different CNS penetration were compared in vivo. Oral administration of either A-784168 (1-[3-(trifluoromethyl)pyridin-2-yl]-N-[4-(trifluoromethylsulfonyl)phenyl]-1,2,3,6-tetrahydropyridine-4-carboxamide) (good CNS penetration) or A-795614 (N-1H-indazol-4-yl-N'-[(1R)-5-piperidin-1-yl-2,3-dihydro-1H-inden-1-yl]urea) (poor CNS penetration) blocked capsaicin-induced acute pain with the same potency. In complete Freund's adjuvant (CFA)-induced chronic inflammatory pain, oral administration of either compound blocked thermal hyperalgesia with similar potency. Furthermore, intraplantar or intrathecal administration of A-784168 blocked CFA-induced thermal hyperalgesia, suggesting that both peripheral and CNS TRPV1 receptors may play a role in inflammatory thermal hyperalgesia.
2.Role of TRPV1 and ASIC3 in formalin-induced secondary allodynia and hyperalgesia.
Martínez-Rojas VA;Barragán-Iglesias P;Rocha-González HI;Murbartián J;Granados-Soto V Pharmacol Rep. 2014 Dec;66(6):964-71. doi: 10.1016/j.pharep.2014.06.011. Epub 2014 Jun 24.
BACKGROUND: ;In the present study we determined the role of transient receptor potential V1 channel (TRPV1) and acid-sensing ion channel 3 (ASIC3) in chronic nociception.;METHODS: ;1% formalin was used to produce long-lasting secondary allodynia and hyperalgesia in rats. Western blot was used to determine TRPV1 and ASIC3 expression in dorsal root ganglia.;RESULTS: ;Peripheral ipsilateral, but not contralateral, pre-treatment (-10min) with the TRPV1 receptor antagonists capsazepine (0.03-0.3μM/paw) and A-784168 (0.01-1μM/paw) prevented 1% formalin-induced secondary mechanical allodynia and hyperalgesia in the ipsilateral and contralateral paws. Likewise, peripheral ipsilateral, but not contralateral, pre-treatment with the non-selective and selective ASIC3 blocker benzamil (0.1-10μM/paw) and APETx2 (0.02-2μM/paw), respectively, prevented 1% formalin-induced secondary mechanical allodynia and hyperalgesia in both paws. Peripheral ipsilateral post-treatment (day 6 after formalin injection) with capsazepine (0.03-0.3μM/paw) and A-784168 (0.01-1μM/paw) reversed 1% formalin-induced secondary mechanical allodynia and hyperalgesia in both paws. In addition, peripheral ipsilateral post-treatment with benzamil (0.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related TRP Channel Products


CAS 2444-46-4 Nonivamide

Nonivamide
(CAS: 2444-46-4)

Nonivamide, also called as N-Vanillylnonanamide, a synthetic analogue of Capsaicin isolated from peppers, is a VR1 (TRPV1) agonist.

CAS 1333210-07-3 SAR7334

SAR7334
(CAS: 1333210-07-3)

SAR7334, a TRPC6 inhibitor, could be valuable in studying sorts of diseases related to TRPC.

CAS 581809-67-8 A 425619

A 425619
(CAS: 581809-67-8)

A 425619 is a potent and selective TRPV1 antagonist (IC50 = 3-9 nM) that inhibits TRPV1 activation by anandamide and N-arachidonoyl-dopamine. A 425619 exhibits ...

CAS 1031496-06-6 CIM 0216

CIM 0216
(CAS: 1031496-06-6)

CIM 0216 has been found to be a selective TRPM3 agonist and could stimulate the release of insulin from pancreatic islet cells.

CAS 926023-82-7 AMTB hydrochloride

AMTB hydrochloride
(CAS: 926023-82-7)

The hydrochloride salt form of AMTB, which has been found to be a TRPM8 channel blocker.

CAS 198022-70-7 AM 404

AM 404
(CAS: 198022-70-7)

AM 404 has been found to be an anandamide transport inhibitor and proved to exhibit effective in activating native and cloned vanilloid receptors.

CAS 1154-25-2 EIPA

EIPA
(CAS: 1154-25-2)

EIPA is a TRPP3 channel inhibitor (IC50 = 10.5 μM). EIPA also acts as an Na+/H+ exchange inhibitor that suppresses the Na+/H+ exchanger (NHE).

CAS 1459809-09-6 AC 4

AC 4
(CAS: 1459809-09-6)

AC 4 is a photoswitchable TRPV1 channel blocker (IC50 = 3.1 μM) that converts TRPV1 channels into photoreceptors.

Chemical Structure

CAS 824982-41-4 A 784168

Quick Inquiry

Verification code

Featured Items